Frontline plc
FRO
Sync financial data to generate a health grade for this company.
Analytical Summary
On an absolute basis, Frontline plc shows solid but mixed fundamentals. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.
18-Year Financial Trajectory
Quarterlyinfo Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.
Dividend History
Dividend / share · sourced from SEC filingsNo quarterly dividend data reported to the SEC.
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q4 FY2025 Dec 31, 2025 20-F ↗ | Q4 FY2024 Dec 31, 2024 20-F ↗ | Q4 FY2023 Dec 31, 2023 20-F ↗ | Q4 FY2022 Dec 31, 2022 20-F ↗ | Q4 FY2021 Dec 31, 2021 20-F ↗ | Q4 FY2020 Dec 31, 2020 20-F ↗ | Q4 FY2019 Dec 31, 2019 20-F ↗ | Q4 FY2018 Dec 31, 2018 20-F ↗ | Q4 FY2017 Dec 31, 2017 20-F ↗ | Q4 FY2016 Dec 31, 2016 20-F ↗ | Q4 FY2015 Dec 31, 2015 20-F ↗ | Q4 FY2014 Dec 31, 2014 20-F ↗ | Q4 FY2013 Dec 31, 2013 20-F ↗ | Q4 FY2012 Dec 31, 2012 20-F ↗ | Q4 FY2011 Dec 31, 2010 20-F ↗ | Q4 FY2010 Dec 31, 2009 20-F ↗ | Q4 FY2009 Dec 31, 2008 20-F ↗ | Q4 FY2008 Dec 31, 2007 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt to Equity (x) | — | — | — | — |
1.42x
Caution
↑
Caution
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+102%)
|
1.34x
Caution
→
Caution
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+91%)
|
1.13x
Caution
→
Caution
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+61%)
|
1.50x
Caution
↑
Caution
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+114%)
|
1.34x
Caution
↑
Caution
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+92%)
|
0.66x
Fair
↑
Fair
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-5%)
|
0.56x
Good
↑
Good
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-20%)
|
0.46x
Good
↑
Good
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-34%)
|
-17.03x
Excellent
↓
Excellent
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-2533%)
|
4.29x
Weak
↑
Weak
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+513%)
|
1.59x
Weak
Weak
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+128%)
|
1.03x
Caution
Caution
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+47%)
|
— | — |
| Net Debt (USD) | — | — | — | — | $2.23B | $1.98B | $1.53B | $1.67B | $1.49B | $790.23M | $541.93M | $281.77M | $405.32M | $352.95M | $1.01B | $678.12M | $-190.82M | $-168.43M |
| Metric | Q4 FY2025 Dec 31, 2025 20-F ↗ | Q4 FY2024 Dec 31, 2024 20-F ↗ | Q4 FY2023 Dec 31, 2023 20-F ↗ | Q4 FY2022 Dec 31, 2022 20-F ↗ | Q4 FY2021 Dec 31, 2021 20-F ↗ | Q4 FY2020 Dec 31, 2020 20-F ↗ | Q4 FY2019 Dec 31, 2019 20-F ↗ | Q4 FY2018 Dec 31, 2018 20-F ↗ | Q4 FY2017 Dec 31, 2017 20-F ↗ | Q4 FY2016 Dec 31, 2016 20-F ↗ | Q4 FY2015 Dec 31, 2015 20-F ↗ | Q4 FY2014 Dec 31, 2014 20-F ↗ | Q4 FY2013 Dec 31, 2013 20-F ↗ | Q4 FY2012 Dec 31, 2012 20-F ↗ | Q4 FY2011 Dec 31, 2010 20-F ↗ | Q4 FY2010 Dec 31, 2009 20-F ↗ | Q4 FY2009 Dec 31, 2008 20-F ↗ | Q4 FY2008 Dec 31, 2007 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Working Capital (USD) | — | — | — | — | $40.07M | $96.96M | $-399.63M | $94.03M | $99.61M | $200.88M | $225.43M | $199.70M | $129.38M | $205.41M | $84.19M | $177.82M | — | — |
| LT Debt (USD) | — | — | — | — | $2.34B | $2.16B | $1.70B | $1.74B | $1.59B | $992.63M | $806.46M | $517.58M | $459.08M | $513.51M | $1.19B | $760.70M | — | — |
| Total Equity (USD) | — | — | — | — | $1.65B | $1.61B | $1.51B | $1.16B | $1.19B | $1.50B | $1.45B | $1.12B | $-26.95M | $119.67M | $747.13M | $741.34M | — | — |
Secondary lens
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Unavailable
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Benchmarks unavailable
Verdicts use absolute quality thresholds, not peer comparison — only 0 comparable companies are currently available for ranking.
Use Statement Evidence firstCompare FRO with peers
Stack FRO against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 18 years · 18 quarters